Form 4: Metagenomi CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Pamela Wapnick, CFO of Metagenomi, Inc., sold 1,808 shares of common stock on March 5, 2025, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- Pamela Wapnick, the Chief Financial Officer of Metagenomi, Inc. (MGX), reported a transaction involving the sale of company stock.
- On March 5, 2025, Wapnick sold 1,808 shares of common stock at a weighted average price of $1.8748 per share.
- The sale was executed to satisfy tax withholding obligations arising from the vesting of restricted stock units granted on April 1, 2024.
- Following the transaction, Wapnick directly owns 59,684 shares of Metagenomi common stock.
Sentiment
Score: 6
Explanation: The document is neutral. It reports a routine transaction (stock sale for tax obligations) by a company insider. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Sales to cover tax obligations are common and don't necessarily reflect a negative outlook on the company.
Key Dates
| Date | Description |
|---|---|
| April 1, 2024 | Date of grant of restricted stock units to Pamela Wapnick. |
| March 5, 2025 | Date of stock sale by Pamela Wapnick to cover tax obligations. |
| March 7, 2025 | Date of signature of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.